1. Home
  2. GLAS vs ARVN Comparison

GLAS vs ARVN Comparison

Compare GLAS & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glass House Brands Inc. Subordinate Voting Shares

GLAS

Glass House Brands Inc. Subordinate Voting Shares

N/A

Current Price

$2.37

Market Cap

504.2M

Sector

Health Care

ML Signal

N/A

Logo Arvinas Inc.

ARVN

Arvinas Inc.

N/A

Current Price

$7.56

Market Cap

600.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLAS
ARVN
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
504.2M
600.2M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
GLAS
ARVN
Price
$2.37
$7.56
Analyst Decision
Strong Buy
Buy
Analyst Count
3
15
Target Price
$9.00
★ $14.54
AVG Volume (30 Days)
★ 2.5M
679.4K
Earning Date
11-16-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 58.84
EPS
N/A
★ 1.70
Revenue
N/A
★ $262,600,000.00
Revenue This Year
$6.93
$12.96
Revenue Next Year
$21.01
N/A
P/E Ratio
★ N/A
$4.65
Revenue Growth
★ N/A
N/A
52 Week Low
$1.67
$6.74
52 Week High
$12.70
$14.22

Technical Indicators

Market Signals
Indicator
GLAS
ARVN
Relative Strength Index (RSI) 22.56 48.35
Support Level $1.67 $6.74
Resistance Level $10.53 $7.77
Average True Range (ATR) 0.39 0.36
MACD 0.12 0.09
Stochastic Oscillator 33.91 62.79

Price Performance

Historical Comparison
GLAS
ARVN

About GLAS Glass House Brands Inc. Subordinate Voting Shares

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: